| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |